Nasdaq(NDAQ)
Search documents
Ribbon Communications Announces Inducement Equity Grants to John Townsend Under Nasdaq Listing Rule 5635(c)(4)
Prnewswire· 2024-10-15 21:30
PLANO, Texas, Oct. 15, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and IP optical networking solutions to many of the world's largest service providers, enterprises, and critical infrastructure operators to modernize and protect their networks, today announced that, in connection with his appointment as Chief Financial Officer, the Board of Directors has awarded John Townsend, as inducement awards, sign-on equity grants consisting ...
Biodexa Announces Successful Appeal of Nasdaq Delisting
GlobeNewswire News Room· 2024-10-15 20:15
Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the "Company") (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced today that a Nasdaq Hearings Panel (the "Panel") has granted the Company's request for an extension of time to demonstrate compliance with the $1.00 minimum bid price requirement for continu ...
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
Benzinga· 2024-10-15 18:14
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 150 points on Tuesday.The Dow traded down 0.30% to 42,937.44 while the NASDAQ fell 0.84% to 18,347.17. The S&P 500 also fell, dropping, 0.43% to 5,834.67.Check This Out: How To Earn $500 A Month From Morgan Stanley Stock Ahead Of Q3 EarningsLeading and Lagging SectorsReal estate shares jumped by 2% on Tuesday.In trading on Tuesday, energy shares fell by 2.3%.Top HeadlineJohnson & Johnson JNJ reported upbeat results ...
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
Prnewswire· 2024-10-15 13:00
NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that on October 14, 2024, Seelos Therapeutics, Inc. (the "Company") received notice that the Nasdaq Hearings Panel (the "Panel") had determined to delist the Company's common stock from The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's f ...
Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date
GlobeNewswire News Room· 2024-10-14 12:00
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on October 15, 2024 at 11:59 PM Eastern Time, before the opening of trading on The Nasdaq Capital ...
X3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Requirement
Prnewswire· 2024-10-11 20:30
SINGAPORE, Oct. 11, 2024 /PRNewswire/ -- X3 Holdings Co., Ltd. (Nasdaq: XTKG) (the "Company" or "XTKG"), a global provider of digital solutions and technology services spanning diverse industries, today announced that it has received an extension of 180 calendar days from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capi ...
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Prnewswire· 2024-10-11 20:30
AUSTIN, Texas, Oct. 11, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that on October 9, 2024, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an aggregate of 24,000 shares of the Company's common stock. Each of these awards was granted under the Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be sub ...
Nano Labs Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
GlobeNewswire News Room· 2024-10-11 12:00
HANGZHOU, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, announced today that it received a written notice from the Listing Qualifications Staff of Nasdaq on October 10, 2024, notifying the Company that it has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “Rule”). T ...
FangDD Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire News Room· 2024-10-11 12:00
SHENZHEN, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (“FangDD” or the “Company”) (Nasdaq: DUO) today announced that the Company received a notification letter (the “Compliance Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), dated October 10, 2024, indicating that the Company regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). As previously announced, the Company was notified by Nasd ...
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2024-10-10 20:40
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 258,800 shares of its common stock to twenty-seven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements mat ...